Fiscal 2021: – Bayer: Dynamic growth – progress in innovation

Group sales increase by 8.9 percent (Fx & portfolio adj.) to 44.081 billion euros / EBITDA before special items declines by 2.5 percent to 11.179 billion euros – inflation-related increase in costs and negative currency effects largely offset / Crop Science grows sales by double-digit percentage (Fx & portfolio adj.) and increases earnings / Pharmaceuticals posts higher sales – earnings decline slightly year on year due to extensive forward-looking investment / Consumer Health delivers ex…

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=285958

Source: Webwire.com
Fiscal 2021: – Bayer: Dynamic growth – progress in innovation